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N-terminal peptides of bovine ribonuclease (RNase) of 20, 13 and 7 amino acid residues were isolated by 
reversed-phase high-performance liquid chromatography (HPLC). Antibodies were raised in mice against 
these peptides coupled to bovine serum albumin (BSA). It was shown that antibodies against the peptides 
reacted with the intact protein and that the immune response decreased with decreasing size of peptide. In 
order to obtain a satisfactory reaction with the intact protein, the peptide immunogen should be longer 
than 7 amino acids. 
Antipeptide antibody Ribonuclease 
1. INTRODUCTION 
There is a rapidly growing interest in antibodies 
elicited against peptides which react with the intact 
protein [I]. It has been shown that the generation 
of such antibodies is a high-frequency event [2] 
which cannot easily be rationalized if a random 
conformation is assumed for small peptides in 
solution. Here, the importance of peptide length 
for the generation of such antibodies is investigated 
by using peptide fragments of a protein (bovine 
ribonuclease) of which the amino acid sequence [3] 
and the tertiary structure ]4,5] are known. 
2. MATERIALS AND METHODS 
2.1. Isolation of peptide fragments 
Peptide I-20 was obtained by limited proteolysis 
of bovine ribonuclease (Miles-Seravac, Maiden- 
head, England) with subtilopeptidase A (Fluka 
AG, Buchs, Switzerland) as described [6]. 
Abbreviations: RNase, bovine ribonuclease; HPLC, 
high-performance liquid chromatography; BSA, bovine 
serum albumin 
Secondary structure Immunization 
Peptide l-13 was obtained by CNBr-treatment 
of RNase. RNase (10 mg/mI) in 70% formic acid 
was treated with a lOO-fold molar excess (with 
respect to the 4 methionines in RNase) of CNBr 
(Fluka) for 19 h at room temperature. The reaction 
mixture was diluted with water and lyophiiized. 
Peptide I-13 was obtained by gel filtration on a 
Sephadex G-25 (fine) column (157 x 1 cm) in 0.2 M 
acetic acid at a flow-rate of 7 ml/h. The absor- 
bance was monitored at 230 nm and fractions (1.2 
ml) were analyzed by high-voltage paper elec- 
trophoresis at pH 3.5 [7]. 
To obtain peptide 1-7, performic acid-oxidized 
RNase [8] was digested with trypsin TPCK (Milli- 
pore, Freehold, NJ, USA) in 0.1 M ammonium- 
bicarbonate (pH 8.2) at an E/S ratio of 1: 100 
(w/w) for 4 h at 37OC. The reaction was ter- 
minated by Iyophilization. The peptide mixture 
was fractionated by gel filtration and analyzed as 
described above for peptide l-13. The fractions 
containing peptide l-7 were further purified by 
preparative high-voltage paper electrophoresis 171. 
2.2. Further purification and amino acid analysis 
Peptides were further purified by reversed-phase 
HPLC on a column (30 x 0.46 cm) of Nucleosil 10 
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C-18 (Macherey-Nagel, Duren, FRG) which was 
eluted with a linear gradient of acetonitrile in 0.1% 
trifluoroacetic acid at a flow-rate of 1 ml/min. The 
absorbance was monitored at 214 nm. 
Amino acid analysis was performed with a Kon- 
tron Liquimat III amino acid analyzer. Samples 
were hydrolyzed as described [7]. 
2.3. Preparation of peptide conjugates and 
immunization 
Peptdies were coupled to BSA with glutaralde- 
hyde [9]. The percentage coupling was determined 
by amino acid analysis. 
C57Bl mice (3-4 per group) were immunized by 
intraperitoneal injection of 0.1 ml of peptide con- 
jugate diluted with an equal volume of Freunds 
complete adjuvant. A booster injection was given 
3 weeks later. Mice were bled after 5 weeks and the 
serum was collected. Each mouse received approx. 
5Opg BSA with 7 pg peptide per injection. Control 
groups received either RNase (10 pg per injection) 
or BSA (50 pg per injection). 
The immune response was determined by inac- 
tivation of a bacteriophage T4-RNase conjugate 
[lo]. RNase was coupled to phage T4 with glutar- 
aldehyde. Antiserum dilutions were incubated with 
a suitable dilution of the phage T4-conjugate at 
37°C for 2 h. The mixtures were plated with 
Escherichia coli B and incubated overnight at 
37°C. The % immune response was calculated 
from the degree of inactivation. The immune 
response obtained with antiserum from mice im- 
munized with RNase was taken as 100% (minimal 
number of plaques) and the response obtained with 
antiserum against BSA was taken as 0% (maximal 
number of plaques). The 070 immune response ob- 
tained by immunization with the peptide-conjugates 
was determined with lo-, 25- and 50-times diluted 
antiserum from the number of plaques. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the location of the HPLC-purified 
peptides in the structure of ribonuclease. Table 1 
shows their amino acid composition. The % coupl- 
ing of peptides to BSA was more than 90%. The 
immune response obtained by immunization with 
the peptide-BSA conjugates was investigated in in- 
dividual mice and the results are shown in fig.2. 
The immune response varies considerably in in- 
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Fig.1. The location of the tryptic peptide l-7, the 1-13 
fragment obtained by cyanogen bromide treatment and 
the l-20 peptide resulting from subtilisin digestion in the 
structure of bovine pancreatic ribonuclease. 
dividual mice immunized with the same peptide 
but is highest in mice immunized with peptide l-20 
and lowest after immunization with the l-7 pep- 
tide. 
The finding that antibodies to a stretch of con- 
secutive amino acids of a protein, i.e., a peptide, 
may react with the intact protein has opened new 
fields of investigation [ 1,2]. Surprisingly, most an- 
tibodies reacted far better than expected with the 
native protein [2]. One of the explanations was 
that the conformation of the peptide in solution 
might be less random than expected from physico- 
chemical studies. A recent study [ll] shows that 
the conformation of a 21-residue C-terminal pep- 
tide is random in water but helical in a more 
hydrophobic environment. This suggests that the 
inherent potential of a peptide to exist in a par- 
ticular secondary structure might be positively in- 
fluenced by its environment, i.e., coupling the pep- 
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Table 1 
Amino acid composition of peptides l-20, 1-13 and 1-7 
Peptide 
Asp 
Thr 
Ser 
Hser + Hserlact 
Glu 
Ala 
h/ret 
Phe 
LYS 
His 
Arg 
I-20 1-13 l-7 
1.2 (1) 
2.0 (2) 1.0 (1) 0.9 (1) 
3.0 (3) 
0.9 (1) 
3.1 (3) 3.3 (3) 1.0 (1) 
5.0 (5) 3.1 (3) 3.0 (3) 
1.1 (1) 
0.9 (I) 1.0 (I) 
2.3 (2) 1.8 (2) 2.0 (2) 
1.0 (1) 1.0 (I) 
I.0 (1) 1.0 (i) 
Methionine is converted to homoserine and 
homoserineiactone. The expected composition of the 
peptides derived from the amino acid sequence (see 
below) is shown in parentheses. Lys-Glu-Thr-Ala-Ala- 
Ala-Lys-Phe-Glu-Arg-Gln-His-Met-Asp-Ser-Ser-Thr- 
Ser-Ala-Ala 
tide to a protein carrier or during the process of 
eliciting antibodies. It might be argued that a 
longer peptide will facilitate the folding to a secon- 
dary structure which is also present in the native 
protein. Therefore, it is plausible that immuniza- 
tion with peptides longer than 7 amino acids will 
result in a higher immune response and a better 
reaction of antipeptide antibodies with the intact 
protein than smaller peptides which have less 
possibilities to exist in an adequate immunogenic 
structure, In addition, the possibility that a longer 
peptide comprises more than one antigenically im- 
ANTISERUM DILUTION 
Fig.2. immune response of mice immunized with RNase 
peptides conjugated to BSA. 0, Peptide l-20; A, 
peptide 1-13; w , peptide 1-7. The lines represent 
immune responses of individual mice. 
portant region may play a role. Shapira et al. [12f 
synthesized 8-, IS- and 27-residue peptides cor- 
responding to the amino acid sequence of W3 in- 
ff uenza hemagglutinin. Immunization with the 1% 
and 27-residue peptides resulted in antibodies 
which reacted with the intact virus, while an- 
tibodies against the S-residue peptide did not bind 
the intact virus. These resuIts suggest hat peptides 
should be longer that 8 amino acids in order to ob- 
tain antibodies capable of reaction with the intact 
viral protein. 
Recently, it was shown that there is a good cor- 
relation between the temperature factors of the 
main chain atoms and antigenicity [13]. The 
temperature factors for the main chain atoms, i.e., 
the mobiIity of the N-terminal region of RNase IS], 
show (fig.3) that there is a good agreement with the 
accessibility of the side-chains as calculated by Lee 
and Richards [ 141. Although a considerable amount 
of the antigenic regions will not be present in a 
linear amino acid sequence, flexible and accessible 
parts of a protein might be the first choice for pep- 
tide synthesis. 
Therefore, it is concluded that peptides of more 
than 7 amino acids which are located in a flexibIe 
and accessible region of the intact protein are most 
suitable for the production of antipeptide an- 
tibodies which will react with the intact protein. 
Very often the N- or C-terminal region of a protein 
will meet these criteria. 
Fig.3. Side-chain accessibility (top) as determined by Lee 
and Richards [14] for RNase S. From the X-ray structure 
of RNase A [5] maximal accessibility was assumed for 
amino acids 15-20. The main chain temperature factors 
(bottom) are from (51. The amino acid sequence of the 
N-terminal region of RNase is shown in the one-fetter 
code and the alpha-helix is also indicated. 
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